Qatar's healthcare sector exports witness significant growth

As one of the fastest-growing economies in the Middle East region, Qatar is home to several industries that catalyze change and supply raw material for diverse products that form a major part of Qatar’s exports, thereby augmenting the nation’s economic growth and development.

By bringing progress to the various areas of the health system continuum, Qatar’s healthcare system has recently claimed the 5th rank globally and the 1st in the Middle East in terms of infrastructure, health outcomes, and life expectancy, with the country’s healthcare spending becoming among the highest in the region. The country has also shown significant success in the fight against the COVID-19 pandemic, with one of the lowest death rates recorded due to the novel coronavirus.

According to experts in the field, the outlook for Qatar’s health sector remains promising, amid the rising demand for pharmaceuticals worldwide. Today, the majority of the companies operating in the sector – which have achieved end-consumer confidence in the superior quality of their products and services – are building on their existing customer base in Qatar by expanding their business interests worldwide.

To facilitate their growth and expansion globally with confidence, healthcare and pharmaceutical companies and suppliers in the country are leveraging the State’s export capabilities and advantages. These include securing the necessary cash flow and providing guarantees against non-payment through a variety of programs and initiatives launched by the State. This is in addition to harnessing various platforms that allow them to identify sustainable export opportunities and tap into regional and global markets through exhibitions, match-making, trade missions, and other means, through the State’s export development and promotion services.

Thanks to Qatar’s integrated export support system, companies in the healthcare sector have achieved remarkable success in terms of overseas expansion and growth. For instance, the GMP-accredited QLife Pharma is today a key player in the pharmaceutical industry in the Middle East and Africa with a strong platform to serve international markets.

Qatar Pharma is another cGMP-accredited company enjoying similar success, with an annual production capacity of 26 million PP Bags, 20 million PE Bottles, 3 million Jerry Cans Haemodialysis Acid Concentrate, and 10 million Topical Drugs for external use including creams, ointments, liniments, hair tonics, disinfectant, and antiseptics. The Company exports close to 85% of its production.

Meanwhile, Qatari German Medical Devices (QGMD) has become a major contender in the medical devices industry supplying the European market with superior quality patient-centric products including its latest-tech Q-Ject single-use syringe, Q-Flow single-use intravenous cannula, and Q-Ject Ultra unibody insulin syringe. The Company has many accreditations and certifications including ISO 9001, ISO 13485, MDD 93/42/EEC Compliance for CE Mark, Russian PCT, and Validated Clean Room ISO Class 6 certifications.